Cementless femoral fixation in total hip arthroplasty (THA) continues to rise worldwide, accompanied by the increasing abandonment of cemented femoral fixation. Cementless fixation is known to contribute to higher rates of post-operative complications and reoperations. New data is available from the Centers for Medicare and Medicaid Services (CMS) regarding total costs of care from the Bundled Payment for Care Improvement (BPCI) and Comprehensive Care for Joint Replacement (CJR) initiatives. How does femoral fixation affect (1) 90-day costs; (2) readmission rates; (3) re-operation rates; (4) length of stay (LOS); and (5) discharge disposition for Medicare patients undergoing elective or non-elective THA?Background
Questions/purposes
Cementless acetabular fixation in total hip replacement (THA) is reliable and has been the fixation method of choice in the United States for decades. While revision for failure of osseointegration or early loosening is relatively rare, recurrent dislocation remains a leading cause of early revision. Novel acetabular implants and those offered by smaller companies often lack constrained or dual mobility liners, which may result in revision of well-fixed, well-positioned cups in cases of recurrent dislocation. The purpose of this study was to compare outcomes of THA with three different acetabular cups with differing fixation surfaces. One hydroxyapatite (HA)-coated cup (Trident, Stryker, Kalamazoo, MI, USA) offered dual mobility or constrained liner options. The other cups were a novel highly porous cup (Restoris PST, Stryker, Kalamazoo, MI, USA), and a Calcium Phosphate (CaP)-coated cup (Trinity, Corin, Cirincester, UK), neither of which offered dual mobility or constrained options at the time of investigation. Endpoints of interest were: clinical and radiographic outcomes including evidence of osseointegration, overall reoperations, reoperations for acetabular fixation failure, and reoperations to address dislocation in which a well-positioned shell was revised due to the lack of dual mobility or constrained options. A retrospective review of 370 acetabular cups implanted in 328 patients for THA by a single surgeon between February 2013 and June 2016 was performed. There were 100 Trident cups (Stryker, Kalamazoo, MI, USA), 105 Restoris PST Acetabular Cups (Stryker, Kalamazoo, MI, USA), and 165 Trinity Acetabular Cups (Corin, Cirincester, UK). Patient records were reviewed for post-operative complications, clinical outcomes scores and radiographic signs of acetabular osseointegration at minimum 1-year follow-up.Introduction
Methods
